Laboratory Of America Holdings
Open
$260.79
Prev. Close
$260.85
High
$260.79
Low
$260.79
Market Snapshot
$21.32B
24.3
8.89
$13.01B
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
emptyResult
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Recently from Cashu

Labcorp Launches First FDA-Cleared Rapid Fentanyl Urine Test for Emergency Care
Labcorp, a major player in laboratory services, has recently introduced the Labcorp Fentanyl Urine Visual Test, the first rapid test for fentanyl that has received clearance from the FDA in the United…
Illumina and Labcorp Enhance Precision Oncology Through Expanded Collaboration and Innovative Testing Solutions
Advancing Precision Oncology: Illumina and Labcorp’s Innovative Partnership In a significant development for precision oncology, Illumina, Inc. and Labcorp announce an expanded collaboration aimed at…
Illumina and Labcorp Collaborate to Revolutionize Precision Oncology and Diagnostic Access
Pioneering Precision Oncology: Illumina and Labcorp Collaboration Enhances Diagnostic Access In a significant development for the field of precision oncology, Illumina, Inc. and Labcorp announce an ex…
Illumina and Labcorp Partner to Enhance Precision Oncology through Advanced Diagnostic Technologies
Illumina and Labcorp Forge New Partnership to Advance Precision Oncology Illumina, Inc. and Labcorp have recently announced an expanded collaboration aimed at significantly enhancing precision oncolog…